NEW YORK, May 15 /PRNewswire/ -- Gerson Lehrman Group, the world's leading marketplace for expertise, today announced a partnership with iGuard.org, a Web-based community devoted to providing patients with the medication information they need to actively manage their own healthcare. iGuard.org provides personalized iGuard Risk Ratings, iGuard Safety Alerts, and a forum for patients to share their experience with other registered users who also want to get informed, stay informed, and share feedback about their medications.
Through this collaboration, Gerson Lehrman Group's clients, including many of the world's leading professional service firms, corporations, nonprofits, and financial services firms will now be able to tap the collective experience of iGuard.org's online patient community through surveys and research projects.
"We are very pleased to enter into this unique partnership with iGuard.org. By leveraging Gerson Lehrman Group's established Web-based tools and platforms, we can now provide the world's leading decision makers with an organized, effective approach to tap into a large patient community," said Alexander Saint-Amand, President and CEO of Gerson Lehrman Group. "Through this relationship, we can take an important step toward including patients' voices when educating professionals, so that they can make more informed healthcare decisions."
"We have seen tremendous response from the patient community to our mission of increasing and improving communication," said Hugo Stephenson, MD, Founder and President of iGuard.org. "This relationship with Gerson Lehrman Group is a natural extension of that effort, enabling patients to share their thoughts and preferences with those entities that can affect changes in the healthcare industry."
This collaboration brings together more than 175,000 experts in the GLG
Councils with over 200,000 patients who are members of the iGuard.org
community, providing decision makers with th
'/>"/>
| SOURCE Gerson Lehrman Group Copyright©2008 PR Newswire. All rights reserved |